1 Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
2 Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany.
3 Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria.
4 Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria.
5 Center for Translational Genomics and Bioinformatics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
6 Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.
7 Department of Medicine, Harvard Medical School, Boston, MA, USA.
8 University Hospital Heidelberg, Heidelberg, Germany.
9 Laboratory of Hematology and Immunology & Laboratory for Myeloma Research, Vrije Universiteit Brussel (VUB) Belgium, Brussels, Belgium.
10 Department of Neurosurgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany.
11 Institute of Medical Radiology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria.
12 Genes & Disease Group, Department of Dermatology, Medical University of Vienna (MUW), Vienna, Austria.
13 Genes & Disease Group, Department of Laboratory Medicine, Medical University of Vienna (MUW), Vienna, Austria.
14 Functional Genomics of Cancer Unit, Experimental Oncology Division, IRCCS San Raffaele Scientific Institute, Milan, Italy.
15 Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
16 Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. dr_huyu@126.com.
17 Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany. klaus.podar@krems.lknoe.at.
18 Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria. klaus.podar@krems.lknoe.at.
19 Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria. klaus.podar@krems.lknoe.at.